Naphthylthiazoles: Targeting Multidrug-Resistant and Intracellular Staphylococcus aureus with Biofilm Disruption Activity

ACS Infect Dis. 2018 Dec 14;4(12):1679-1691. doi: 10.1021/acsinfecdis.8b00172. Epub 2018 Oct 8.

Abstract

Thirty-two new naphthylthiazole derivatives were synthesized with the aim of exploring their antimicrobial effect on multidrug-resistant Gram-positive bacteria. Compounds 25 and 32, with ethylenediamine and methylguanidine side chains, represent the most promising derivatives, as their antibacterial spectrum includes activity against multidrug-resistant staphylococcal and enterococcal strains. Moreover, the new derivatives are highly advantageous over the existing frontline therapeutics for the treatment of multidrug-resistant Gram-positive bacteria. In this vein, compound 25 possesses three attributes: no bacterial resistance was developed against it even after 15 passages, it was very efficient in targeting intracellular pathogens, and it exhibited a concentration-dependent ability to disrupt the preformed bacterial biofilm.

Keywords: MRSA biofilm; antibiotic resistance; intracellular bacteria clearance; prolonged half-life; vancomycin-resistant Staphylococcus aureus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacology*
  • Biofilms / drug effects*
  • Cell Line
  • Drug Design
  • Drug Resistance, Multiple, Bacterial*
  • Enterococcus / drug effects
  • Enterococcus / growth & development
  • Humans
  • Microbial Sensitivity Tests
  • Staphylococcal Infections / microbiology*
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / genetics
  • Staphylococcus aureus / physiology
  • Structure-Activity Relationship
  • Thiazoles / chemistry*
  • Thiazoles / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Thiazoles